RE
GWPH

RBC Europe’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

RBC Europe’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,664
Closed -$1.45M – 1262
2021
Q1 		$1.45M Sell
6,664
-1,692
-20% -$318K 0.08% 120
2020
Q4 		$964K Sell
8,356
-298
-3% -$33.4K 0.06% 140
2020
Q3 		$842K Hold
8,654
– – 0.06% 134
2020
Q2 		$1.06M Sell
8,654
-294
-3% -$33.4K 0.08% 121
2020
Q1 		$784K Hold
8,948
– – 0.08% 114
2019
Q4 		$936K Hold
8,948
– – 0.08% 124
2019
Q3 		$1.03M Buy
8,948
+70
+0.8% +$10.6K 0.1% 116
2019
Q2 		$1.53M Sell
8,878
-2,989
-25% -$517K 0.15% 97
2019
Q1 		$2M Sell
11,867
-435
-4% -$64.7K 0.22% 82
2018
Q4 		$1.2M Hold
12,302
– – 0.16% 94
2018
Q3 		$2.13M Buy
12,302
+46
+0.4% +$6.63K 0.24% 74
2018
Q2 		$1.71M Sell
12,256
-387
-3% -$55K 0.2% 86
2018
Q1 		$1.42M Sell
12,643
-583
-4% -$73.3K 0.17% 98
2017
Q4 		$1.75M Buy
13,226
+2,605
+25% +$306K 0.21% 86
2017
Q3 		$1.08M Buy
+10,621
New +$1.14M 0.14% 102

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

RBC Europe's GWPH Position: Q2 2021 in Review

RBC Europe sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 6,664 shares — an estimated $1.45M sold.

RBC Europe first reported a position in GWPH in Q3 2017 and held it in 15 quarters. The position peaked at $2.13M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • RBC Europe reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • RBC Europe sold 6,664 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.45M.
  • RBC Europe first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 15 quarters.
  • RBC Europe's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.13M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on RBC Europe's 13F filing for Q2 2021, filed 9 Nov 2023.